ArticleEndocrine, metabolic & immune disorders drug targets2026
An Integrative Analysis of the Role of Mitophagy in Comorbid Myocardial Infarction and Type 2 Diabetes Mellitus.
Article in Endocrine, metabolic & immune disorders drug targets, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCoexisting myocardial infarction (MI) and type 2 diabetes mellitus (T2DM) is a common condition. We aimed to investigate the association between MI and type 2 diabetes (T2D) with mitophagy-related differentially expressed genes (MRDEGs) and the impact thereof on disease progression.
methodsR package was used for data retrieval and normalization of the MI (GSE48060 and GSE29532) and T2D (GSE76894 and GSE25724) datasets. Gene set enrichment analysis indicated significant associations between biological functions and pathways. Protein-protein interaction networks constructed using STRING and GeneMANIA revealed interconnected MRDEGs.
resultsPrincipal component and differential gene expression analyses identified 45 MRDEGs. Through key gene screening, least absolute shrinkage, and selection operator (LASSO) risk model construction, nine MRDEGs were identified: DISCUSSION: This study highlights the significance of immune cell infiltration in the context of MI and T2D. This analysis is primarily based on publicly available datasets, and future research will incorporate independent patient cohorts to assess the role of mitochondrial autophagy in these diseases.
conclusionThe screened genes may be therapeutic targets to prevent progression and improve clinical outcomes in patients with MI and T2D. This study provides an integrative view of mitochondrial metabolism and immune infiltration in MI and T2D, offering a novel direction to further elucidate the pathogenesis and medical interventions for these diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.